BSX

Boston Scientific Corp.

Price

$63.80

return (12m)

p/e

18.45

p/bv

2.54

DIVIDEND YIELD

0.00%

BSX price

Boston Scientific

If you had invested

exposure

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Return on Investment BSX

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

0.00%

3 months

0.00%

1 year

0.00%

2 years

0.00%

5 years

0.00%

10 years

0.00%

Fundamentals BSX

Valuation

P/E

18.45

Sector -2.34

Industry 11.10

P/BV

2.54

Sector 2.17

Industry 3.33

P/Revenue (PSR)

3.19

Sector 2.00

Industry 1.71

EV/EBITDA

Sector -23.69

Industry -398.52

EV/EBIT

-214.02

Sector -36.60

Industry -80.73

P/EBITDA

31.98

Sector -0.10

Industry 8.30

P/EBIT

99.22

Sector -2.08

Industry 5.69

P/Total Assets

1.48

Sector 1.18

Industry 1.57

P/Net Current Assets

Sector -10.91

Industry -3.38

P/Working Capital

Sector 0.09

Industry 10.51

EPS

2.38

Sector -0.93

Industry 1.10

BVPS

17.30

Sector 3.87

Industry 14.82

Efficiency

Gross Margin

70.41%

Sector 44.28%

Industry 29.23%

EBITDA Margin

Sector -291.45%

Industry 4.29%

EBIT Margin

-6.75%

Sector -195.44%

Industry 1.44%

Operating Margin

20.12%

Sector -25.72%

Industry 2.16%

Net Profit Margins

17.29%

Sector -30.19%

Industry 2.77%

Asset Turnover

0.12

Sector 0.12

Industry 0.27

Profitability

ROE

13.78%

Sector -34.71%

Industry 6.97%

ROA

8.04%

Sector -28.76%

Industry 2.97%

ROIC

Sector -441.27%

Industry -5.31%

Dividends

Dividend yield

0.00%

Sector -

Industry 0.01%

Payout

0.00%

Sector -

Industry 0.54%

Debt

Current Ratio

Sector 1.87

Industry 1.51

Net Debt / EBITDA

Sector -2.18

Industry -1.68

Net Debt / EBIT

-26.61

Sector -0.74

Industry -7.00

Net Debt / Equity

0.36

Sector -0.34

Industry 0.05

Gross Debt / Equity

0.42

Sector -0.64

Industry 0.35

Equity/Assets

0.58

Sector 0.43

Industry 0.46

Liabilities/Assets

0.41

Sector 0.46

Industry 0.52

Growth

5Y Revenue CAGR

11.64%

Sector -

Industry -

5Y Earnings CAGR

29.36%

Sector -

Industry -

FAIR VALUE OF Boston Scientific ACCORDING TO BENJAMIN GRAHAM

Graham's Fair Value

The Fair Value formula was created by Benjamin Graham to identify stocks with appreciation potential or that are being traded for less than they are worth. Graham was one of the greatest investors in history and Warren Buffett’s mentor.

Current price

$63.80

Fair Value

$30.44

Upside Return potential.

-52.29%

See Graham's ranking

Because it considers equity value in its calculation, this formula may not work well for technology companies.

This is not a buy/sell recommendation; the fair value calculation takes into account only the formula created by Benjamin Graham, published in the book The Intelligent Investor.

Fundamentals BSX

DRAG THE FRAME TO SEE MORE DATA

Assets	Price (US$)	Return 12m	DY	P/E	P/BV	ROE	Net Profit Margins
BSX Boston Scientific Corp.	$63.80	-31.89%	0.00%	18.45	2.54	13.78%	17.29%
EW Edwards Lifesciences Corp.	$78.21	12.69%	0.00%	45.55	4.82	10.58%	17.34%
ABT Abbott Laboratories	$101.06	-18.35%	0.00%	25.64	3.09	12.06%	13.91%
ABMD Abiomed Inc.	$0.00	-	0.00%	64.27	11.14	17.32%	24.84%
ALGN Align Technology Inc.	$184.69	12.52%	0.00%	27.86	2.89	10.36%	10.50%
BLPH Bellerophon Therapeutics Inc.	$0.00	-	0.00%	0.59	0.13	22.35%	0.00%

Stock vs Indice Comparison Tool

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

BSX Historical Dividends

current DY: 0.00%

5-year average DY: 0.00%

no dividend paid in the period.

ABOUT Boston Scientific

Boston Scientific Corp.

Average Investor10 user rating

4.0 (0 people)

States of America

47 years

Founded: 1979

1992

Time since IPO - 34 years

36.000

Employees

Boston Scientific Corp. (States of America) is listed on the NYSE and has a market capitalization of $65.78 billion, with shareholders equity totaling $25.86 billion.

The company employs approximately 36.000 people and operates in the Saúde sector, within the Materiais e Equipamentos Médicos industry.

Over the past 12 months, Boston Scientific Corp. reported $20.62 billion in revenue, generating net income of $3.57 billion.

Key financial metrics include a P/E ratio of 18.45, a price-to-book (P/B) ratio of 2.54, and a trailing twelve-month dividend yield of 0.00%.

The company trades under the ticker BSX.

Market cap

$65.78 billion

Net worth

$25.86 billion

$25,864,000,000.00

Assets

$44.35 billion

$44,351,000,000.00

Total Shares Outstanding

1.50 billion

1,495,000,000

Average Daily Trading Volume

$17.09 million

$17,092,074.00

Sector

Saúde

Industry

Materiais e Equipamentos Médicos

BSX

revenue by Business Segment Boston Scientific

BSX revenue and profits

Financial Results BSX

DRAG THE FRAME TO SEE MORE DATA

BSX cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

CVS - CVS Health

$77.63 34,88% (12M)

P/E

46.88

2.46%

ROE

3.78%

P/BV

1.77

CI - Cigna

$272.65 --5,23% (12M)

P/E

11.58

2.16%

ROE

15.39%

P/BV

1.78

CNC - Centene

$37.26 38,72% (12M)

P/E

-4.98

0.00%

ROE

-29.93%

P/BV

1.49

HUM - Humana

$196.30 --14,19% (12M)

P/E

42.07

0.89%

ROE

6.06%

P/BV

2.55

SNY - Sanofi

$47.64 --3,72% (12M)

P/E

7.21

4.00%

ROE

17.79%

P/BV

1.28

LLY - Eli Lilly

$923.03 21,62% (12M)

P/E

41.74

0.55%

ROE

81.02%

P/BV

33.82

HCA - HCA Healthcare

$498.78 47,18% (12M)

P/E

12.41

0.80%

ROE

-228.14%

P/BV

-28.31

NVS - Novartis

$153.41 34,63% (12M)

P/E

21.74

2.01%

ROE

34.77%

P/BV

7.56